1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Non Alcoholic Fatty Liver Disease (NAFLD) Global Clinical Trials Review, H1, 2015

Non Alcoholic Fatty Liver Disease (NAFLD) Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Non Alcoholic Fatty Liver Disease (NAFLD) Global Clinical Trials Review, H1, 2015" provides data on the Non Alcoholic Fatty Liver Disease (NAFLD) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Non Alcoholic Fatty Liver Disease (NAFLD). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Non Alcoholic Fatty Liver Disease (NAFLD). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Non Alcoholic Fatty Liver Disease (NAFLD) Global Clinical Trials Review, H1, 2015
Table of Contents
Introduction 6
Non Alcoholic Fatty Liver Disease (NAFLD) 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Non Alcoholic Fatty Liver Disease (NAFLD) to Gastrointestinal Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Non Alcoholic Fatty Liver Disease (NAFLD) to Gastrointestinal Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Non Alcoholic Fatty Liver Disease (NAFLD) 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics Clinical Trials 30
Prominent Drugs 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Galmed International Ltd. 32
Clinical Trial Overview of Galmed International Ltd. 32
AstraZeneca PLC 33
Clinical Trial Overview of AstraZeneca PLC 33
TCM Biotech International Corp 34
Clinical Trial Overview of TCM Biotech International Corp 34
Phenex Pharmaceuticals AG 35
Clinical Trial Overview of Phenex Pharmaceuticals AG 35
PharmaKing Co., Ltd. 36
Clinical Trial Overview of PharmaKing Co., Ltd. 36
Genextra S.p.a. 37
Clinical Trial Overview of Genextra S.p.a. 37
F. Hoffmann-La Roche Ltd. 38
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 38
Barij essence Company 39
Clinical Trial Overview of Barij essence Company 39
Antipodean Pharmaceuticals, Inc. 40
Clinical Trial Overview of Antipodean Pharmaceuticals, Inc. 40
Abbott Laboratories 41
Clinical Trial Overview of Abbott Laboratories 41
Clinical Trial Overview of Top Institutes / Government 42
Tabriz University of Medical Sciences 42
Clinical Trial Overview of Tabriz University of Medical Sciences 42
Third Military Medical University 43
Clinical Trial Overview of Third Military Medical University 43
Tehran University of Medical Sciences 44
Clinical Trial Overview of Tehran University of Medical Sciences 44
University of Michigan 45
Clinical Trial Overview of University of Michigan 45
The National Institute of Diabetes and Digestive and Kidney Diseases 46
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 46
FUDAN University 47
Clinical Trial Overview of FUDAN University 47
Massachusetts General Hospital 48
Clinical Trial Overview of Massachusetts General Hospital 48
Chinese University of Hong Kong 49
Clinical Trial Overview of Chinese University of Hong Kong 49
Ahvaz Jundishapur University of Medical Sciences 50
Clinical Trial Overview of Ahvaz Jundishapur University of Medical Sciences 50
Bambino Gesu Hospital and Research Institute 51
Clinical Trial Overview of Bambino Gesu Hospital and Research Institute 51
Five Key Clinical Profiles 52
Appendix 80
Abbreviations 80
Definitions 80
Research Methodology 81
Secondary Research 81
About GlobalData 82
Contact Us 82
Disclaimer 82
Source 82

List of Tables

Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics, Global, Clinical Trials by Region, 2015* 7
Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Non Alcoholic Fatty Liver Disease (NAFLD) to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15
Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Non Alcoholic Fatty Liver Disease (NAFLD) to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18
Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics, Global, Withdrawn Clinical Trials, 2015* 25
Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics, Global, Terminated Clinical Trials, 2015* 26
Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 28
Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29
Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30
Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31
Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Galmed International Ltd., 2015* 32
Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2015* 33
Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics Clinical Trials Market, Global, Clinical Trials by TCM Biotech International Corp, 2015* 34
Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Phenex Pharmaceuticals AG, 2015* 35
Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics Clinical Trials Market, Global, Clinical Trials by PharmaKing Co., Ltd., 2015* 36
Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Genextra S.p.a., 2015* 37
Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 38
Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Barij essence Company, 2015* 39
Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Antipodean Pharmaceuticals, Inc., 2015* 40
Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2015* 41
Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Tabriz University of Medical Sciences, 2015* 42
Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Third Military Medical University, 2015* 43
Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2015* 44
Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan, 2015* 45
Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2015* 46
Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics Clinical Trials Market, Global, Clinical Trials by FUDAN University, 2015* 47
Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2015* 48
Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2015* 49
Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Ahvaz Jundishapur University of Medical Sciences, 2015* 50
Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Bambino Gesu Hospital and Research Institute, 2015* 51

List of Figures

Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Proportion of Non Alcoholic Fatty Liver Disease (NAFLD) to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15
Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Non Alcoholic Fatty Liver Disease (NAFLD) to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18
Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 28
Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29
Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30
Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31
GlobalData Methodology 81

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
Liver Cirrhosis- Market Insights, Epidemiology and Market Forecast-2023

Liver Cirrhosis- Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Liver Cirrhosis - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global ...

Peptic Ulcer  - Market Insights, Epidemiology and Market Forecast-2023

Peptic Ulcer  - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Peptic Ulcer - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global ...

Crohn’s disease (CD)- Market Insights, Epidemiology and Market Forecast-2023

Crohn’s disease (CD)- Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Crohn’s disease (CD) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.